Balance Sheet Data

ImmunoGen, Inc. (IMGN)

$5.21

-0.09 (-1.70%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 267.11262.25176.22293.86478.75266.50275.72285.26295.13305.34
Total Cash (%)
Account Receivables 5.2312.0727.2522.5013.9314.0514.5315.0315.5516.09
Account Receivables (%)
Inventories 1.040.480.741.190.630.650.670.700.720.74
Inventories (%)
Accounts Payable 8.5611.379.939.5418.4310.7511.1211.5011.9012.31
Accounts Payable (%)
Capital Expenditure -1.12-5.25-2.85-0.92-1.43-2.46-2.54-2.63-2.72-2.81
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.